Addendum: Low-value approvals and high prices might incentivize ineffective drug development

Addendum: Low-value approvals and high prices might incentivize ineffective drug developmentAddendum: Low-value approvals and high prices might incentivize ineffective drug development, Published online: 12 November 2018; doi:10.1038/s41571-018-0120-1Addendum: Low-value approvals and high prices might incentivize ineffective drug development

https://www.nature.com/articles/s41571-018-0120-1

Source: Nature Clinical Practice Oncology - November 12, 2018 Category: Cancer & Oncology Authors: Vinay Prasad Christopher McCabe Sham Mailankody Source Type: research

More News: Cancer & Oncology